156 related articles for article (PubMed ID: 9182874)
1. Binding of complement component Clq to myelin oligodendrocyte glycoprotein: a novel mechanism for regulating CNS inflammation.
Johns TG; Bernard CC
Mol Immunol; 1997 Jan; 34(1):33-8. PubMed ID: 9182874
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
[TBL] [Abstract][Full Text] [Related]
3. [Myelin oligodendrogliocyte glycoprotein: the structure, functions, role in pathogenesis of demyelinating disorders].
Chekhonin VP; Semenova AV; Gurina OI; Dmitrieva TB
Biomed Khim; 2003; 49(5):411-23. PubMed ID: 16119093
[TBL] [Abstract][Full Text] [Related]
4. Antibody cross-linking of myelin oligodendrocyte glycoprotein leads to its rapid repartitioning into detergent-insoluble fractions, and altered protein phosphorylation and cell morphology.
Marta CB; Taylor CM; Coetzee T; Kim T; Winkler S; Bansal R; Pfeiffer SE
J Neurosci; 2003 Jul; 23(13):5461-71. PubMed ID: 12843245
[TBL] [Abstract][Full Text] [Related]
5. Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis.
Karni A; Bakimer-Kleiner R; Abramsky O; Ben-Nun A
Arch Neurol; 1999 Mar; 56(3):311-5. PubMed ID: 10190821
[TBL] [Abstract][Full Text] [Related]
6. The structure and function of myelin oligodendrocyte glycoprotein.
Johns TG; Bernard CC
J Neurochem; 1999 Jan; 72(1):1-9. PubMed ID: 9886048
[TBL] [Abstract][Full Text] [Related]
7. Demyelinating myelin oligodendrocyte glycoprotein-specific autoantibody response is focused on one dominant conformational epitope region in rodents.
Breithaupt C; Schäfer B; Pellkofer H; Huber R; Linington C; Jacob U
J Immunol; 2008 Jul; 181(2):1255-63. PubMed ID: 18606679
[TBL] [Abstract][Full Text] [Related]
8. A molecular model of myelin oligodendrocyte glycoprotein.
Hjelmström P; Penzotti JE; Henne RM; Lybrand TP
J Neurochem; 1998 Oct; 71(4):1742-9. PubMed ID: 9751210
[TBL] [Abstract][Full Text] [Related]
9. Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein.
O'Connor KC; Appel H; Bregoli L; Call ME; Catz I; Chan JA; Moore NH; Warren KG; Wong SJ; Hafler DA; Wucherpfennig KW
J Immunol; 2005 Aug; 175(3):1974-82. PubMed ID: 16034142
[TBL] [Abstract][Full Text] [Related]
10. Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein.
Breithaupt C; Schubart A; Zander H; Skerra A; Huber R; Linington C; Jacob U
Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9446-51. PubMed ID: 12874380
[TBL] [Abstract][Full Text] [Related]
11. Cloning and cDNA sequence analysis of myelin/oligodendrocyte glycoprotein: a novel member of the immunoglobulin gene superfamily.
Gardinier MV; Matthieu JM
Schweiz Arch Neurol Psychiatr (1985); 1993; 144(3):201-7. PubMed ID: 7687365
[TBL] [Abstract][Full Text] [Related]
12. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat.
Adelmann M; Wood J; Benzel I; Fiori P; Lassmann H; Matthieu JM; Gardinier MV; Dornmair K; Linington C
J Neuroimmunol; 1995 Dec; 63(1):17-27. PubMed ID: 8557821
[TBL] [Abstract][Full Text] [Related]
13. Antibody response in Lewis rats injected with myelin oligodendrocyte glycoprotein derived peptides.
Ichikawa M; Johns TG; Adelmann M; Bernard CC
Int Immunol; 1996 Nov; 8(11):1667-74. PubMed ID: 8943561
[TBL] [Abstract][Full Text] [Related]
14. Signaling cascades activated upon antibody cross-linking of myelin oligodendrocyte glycoprotein: potential implications for multiple sclerosis.
Marta CB; Montano MB; Taylor CM; Taylor AL; Bansal R; Pfeiffer SE
J Biol Chem; 2005 Mar; 280(10):8985-93. PubMed ID: 15634682
[TBL] [Abstract][Full Text] [Related]
15. The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis.
Clements CS; Reid HH; Beddoe T; Tynan FE; Perugini MA; Johns TG; Bernard CC; Rossjohn J
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):11059-64. PubMed ID: 12960396
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology.
Marta CB; Oliver AR; Sweet RA; Pfeiffer SE; Ruddle NH
Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13992-7. PubMed ID: 16172404
[TBL] [Abstract][Full Text] [Related]
17. High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes.
Weissert R; Kuhle J; de Graaf KL; Wienhold W; Herrmann MM; Müller C; Forsthuber TG; Wiesmüller KH; Melms A
J Immunol; 2002 Jul; 169(1):548-56. PubMed ID: 12077287
[TBL] [Abstract][Full Text] [Related]
18. Regulation of myelin oligodendrocyte glycoprotein in different species throughout development.
Slavin AJ; Johns TG; Orian JM; Bernard CC
Dev Neurosci; 1997; 19(1):69-78. PubMed ID: 9078435
[TBL] [Abstract][Full Text] [Related]
19. Demyelinating antibodies to myelin oligodendrocyte glycoprotein and galactocerebroside induce degradation of myelin basic protein in isolated human myelin.
Menon KK; Piddlesden SJ; Bernard CC
J Neurochem; 1997 Jul; 69(1):214-22. PubMed ID: 9202313
[TBL] [Abstract][Full Text] [Related]
20. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.
Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C
Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
